MESA, ARIZONA — November 10, 2025 — Leads & Copy — Medical Care Technologies Inc. (OTC PINK:MDCE) has announced the development of its patent-pending AI health platform, designed to bring real-time diagnostic intelligence directly to smartphones.
The platform, detailed in U.S. Provisional Patent Application No. 63/854,935, aims to enable early detection of high-risk medical conditions without requiring specialized hardware, clinical visits, or expensive imaging devices. MDCE’s system utilizes advanced deep learning, temporal image analysis, and affective computing to identify early health indicators with precision previously limited to clinical environments.
The company is actively developing four core AI verticals:
The AI Mental Health Screening uses high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to identify early signs of anxiety, depression, and PTSD. This targets a digital mental health market exceeding $400 billion globally.
The AI Wound Monitoring analyzes sequential imaging for infection risk, tissue deterioration, and healing progression, impacting the global chronic wound care market projected to surpass $30 billion by 2030.
The AI Skin Cancer Screening employs full-body lesion mapping, 3D indexing, and temporal skin-change detection to enable population-scale early melanoma awareness within a $15+ billion dermatology diagnostics market.
The AI Health Risk Estimator uses facial biometrics, tonal gradient analysis, and multimodal AI to predict disease predisposition and longevity risk, aligning with the rapidly expanding $4 trillion preventative and precision health sector.
MDCE expects to release its first integrated beta consumer app in 2026, marking the company’s transition into commercial deployment.
Marshall Perkins, CEO of Medical Care Technologies Inc., stated that the company’s mission is to make proactive health screening accessible. By enabling earlier risk detection for conditions like melanoma, infections, or mental health decline, MDCE aims to establish a new standard of data-driven healthcare delivered through everyday technology.
Medical Care Technologies Inc. is a healthcare technology company developing AI-powered diagnostic and preventative health solutions designed to make early health awareness accessible worldwide. The company’s proprietary deep learning models and patent-pending mobile screening technology aim to transform smartphones into diagnostic tools for consumers, providers, and payers.
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Source: Medical Care Technologies Inc.
